Oragenics Inc. (AMEX:OGEN) Financings
Financings
| Raise | Date |
|---|---|
| Public offering of series H Convertible Preferred Stock and Warrants Closed: US$16.5M raised · US$25 a share · 1 warrant at US$25 for 60 months · Dawson James Securities, Inc. Dealers: Dawson James Securities, Inc. (lead) Use of proceeds: Clinical development of ONP-002, other R&D, repay a $3 million bridge note, working capital and general corporate purposes | Jul 2, 2025 |